European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin ...Middle East

PR Newswire - News
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
TOKYO and BOTHELL, Wash., March 26, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq: SGEN) today announced that a marketing authorization application (MAA) for enfortumab vedotin was accepted by the...

Hence then, the article about european medicines agency accepts marketing authorization application for enfortumab vedotin was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News